Global Conjunctivitis Market 2015-2019

Conjunctivitis market scope

Conjunctivitis may occur due to allergies and involves the infection of the eye in which the conjunctiva is infected. The patent expiries of few drugs such as Lotemax, Patanol, Pataday, and Lastacaft along with the expected entry of few other drugs into the market during the forecast period are envisaged to result in this market’s slow growth rate of approximately 2% by 2019.

Conjunctivitis market driver

The unmet need for viral conjunctivitis is the key driver for the growth of this market. Since there are no approved drugs for the treatment of viral conjunctivitis, many companies and researchers are now developing drugs that are in the clinical stage of development. These drugs are expected to aid in the treatment of viral conjunctivitis and their effectiveness will, in turn, promote growth in this market in the next four years.

Conjunctivitis market growth: Competitive landscape and key vendors

This market is growing at a moderate pace owing to the loss of patent exclusivities and the augmented use of generics in the market. Since there is no effective treatment option for conjunctivitis, the companies that can effectively treat and cure this disease are expected to gain a competitive edge over their peers during the forecast period.

Key vendors in the conjunctivitis market

• Akorn
• Alcon
• Allergan
• Bausch & Lomb

Conjunctivitis market segment by disease-type 

• Bacterial conjunctivitis
• Viral conjunctivitis
• Allergic conjunctivitis

Technavio’s market research analyst has estimated the allergic conjunctivitis segment to account for more than 41% of the total market share by 2019. This condition is caused due to the different allergens present in the environment and generally leads to constant irritation and inflammation of the conjunctival tissue.

Conjunctivitis industry analysis as per geographical segmentation

• APAC
• EMEA
• Americas

Geographically, the Americas are expected to account for more than 51% of the total market by 2019. Increasing awareness of the infection coupled with the availability of treatment options is expected to result in this region’s high market share during the forecast period.

Key questions answered in the report include

• What will the market size and the growth rate be in 2019?
• What are the key factors driving the global conjunctivitis market?
• What are the key market trends impacting the growth of the global conjunctivitis market?
• What are the challenges to market growth?
• Who are the key vendors in the global conjunctivitis market?
• What are the market opportunities and threats faced by the vendors in the global conjunctivitis market?
• Trending factors influencing the market shares of the EMEA, Americas, and APAC?
• What are the key outcomes of the five forces analysis of the global conjunctivitis market?

Technavio also offers customization on reports based on specific client requirement.